Phentolamine mesylate CAS: 65-28-1
MF: C17H19N3O CH3SO3H
MW: 377.46
An α-adrenergic blocker.

Phentolamine mesylate (CAS 65-28-1)

Phentolamine mesylate | CAS 65-28-1 is rated 5.0 out of 5 by 1.
  • y_2021, m_7, d_30, h_19
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.18
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_205803, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 100ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: Phentolamine Methanesulfonate Salt; 2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline; Methanesulfonate
Application: Phentolamine mesylate is an α-adrenergic blocker
CAS Number: 65-28-1
Purity: ≥99%
Molecular Weight: 377.46
Molecular Formula: C17H19N3O CH3SO3H
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Phentolamine mesylate acts as an α-AR (α-Adrenergic) blocker.


References

McMahon CG. Int J Impot Res. 8:233-6 (1996).

Appearance :
Crystalline powder
Physical State :
Solid
Solubility :
Solubility: Soluble in water, alcohol.
Storage :
Store at room temperature
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
MDL Number :
MFCD00134201
EC Number :
200-604-6
SMILES :
CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Phentolamine mesylate (CAS 65-28-1)  Product Citations

See how others have used Phentolamine mesylate (CAS 65-28-1). Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 24519125  Yang, R. et al. 2014. Braz. J. Med. Biol. Res. 47: 101-9.

Citations 1 to 1 of 1 total

What is the appearance of the compound?

Asked by: two2igm05
Thank you for your question. Phentolamine mesylate, sc-205803, is in white crystalline powder form.
Answered by: Chemical Support 4
Date published: 2017-04-18
  • y_2021, m_7, d_30, h_19CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.18
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_205803, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 116ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Lamkin Lamkin, DM. et al. (PubMed 25462899) reported that 2-adrenergic blockade by Phentolamine mesylate mimics the enhancing effect of chronic stress on breast cancer progression. -SCBT Publication Review
Date published: 2015-02-09
  • y_2021, m_7, d_30, h_19
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.18
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_205803, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT